Quantitation of 47 human tear proteins using high resolution multiple reaction monitoring (HR-MRM) based-mass spectrometry

Journal of Proteomics

Volumn 115, Issue , 2015, Pages 36-48

  Tong, Louis ^a,b,c,d   Zhou, Xi Yuan ^e   Jylha, Antti ^f   Aapola, Ulla ^f   Liu, Dan Ning ^e   Koh, Siew Kwan ^a   Tian, Dechao ^g   Quah, Joanne ^h   Uusitalo, Hannu ^f   Beuerman, Roger W ^a,b,d,f   Zhou, Lei ^a,b,d  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e CHONGQING MEDICAL UNIVERSITY   (China)

^f UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^h SINGHEALTH POLYCLINICS   (Singapore)

Author keywords

High resolution MRM; Human tear proteins; Quantitative proteomics; Targeted proteomics; Tear proteomics

Indexed keywords

ALPHA ENOLASE; APOLIPOPROTEIN A1; BIOLOGICAL MARKER; CALGRANULIN A; CALGRANULIN B; CATHEPSIN D; CLUSTERIN; COMPLEMENT; GELATINASE; GLYCOPROTEIN; HAPTOGLOBIN; HEMOPEXIN; ISOTOPE; LACTATE DEHYDROGENASE; LACTOFERRIN; LIPOCALIN 1; LIPOCORTIN 1; MAMMAGLOBIN B; PEROXIREDOXIN 6; PROLACTIN; PROLINE RICH PROTEIN; PROTEIN 14 3 3; PROTEIN S 100; RETINAL DEHYDROGENASE; SECRETORY COMPONENT; TEAR PROTEIN; THIOREDOXIN; TRYPSIN; UNINDEXED DRUG; ZINC; EYE PROTEIN; TEAR PROTEINS;

ADULT; ARTICLE; ENZYME METABOLISM; FEMALE; HIGH RESOLUTION MULTIPLE REACTION MONITORING; HUMAN; INFORMED CONSENT; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETER; MASS SPECTROMETRY; MIDDLE AGED; PEPTIDE ANALYSIS; PROTEIN ANALYSIS; PROTEOMICS; SCHIRMER STRIP; TIME OF FLIGHT MASS SPECTROMETRY; CLINICAL TRIAL; LACRIMAL FLUID; METABOLISM; PROCEDURES;

EYE PROTEINS; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; TEARS;

EID: 84919941407     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.12.002     Document Type: Article

References (55)

1. Beretta L. Proteomics from the clinical perspective: many hopes and much debate. Nat Methods 2007, 4:785-786.
2. Ohashi, Dogru M., Tsubota K. Laboratory findings in tear fluid analysis. Clin Chim Acta 2006, 369:17-28.
3. Zhou L., Beuerman R.W., Foo Y., Liu S., Ang L.P., Tan D.T. Characterisation of human tear proteins using high-resolution mass spectrometry. Ann Acad Med Singapore 2006, 35:400-407.
4. Zhou L., Beuerman R.W. Tear analysis in ocular surface diseases. Prog Retin Eye Res 2012, 31:527-550.
5. Rolando M., Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol 2001, 45:S203-S210.
6. Zhou L., Zhao S.Z., Koh S.K., Chen L., Vaz C., Tanavde V., et al. In-depth analysis of the human tear proteome. J Proteomics 2012, 75:3877-3885.
7. de Souza G.A., Godoy L.M., Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol 2006, 7:R72.
8. Grus F.H., Podust V.N., Bruns K., Lackner K., Fu S., Dalmasso E.A., et al. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest Ophthalmol Vis Sci 2005, 46:863-876.
9. Zhou L., Beuerman R.W., Chan C.M., Zhao S.Z., Li X.R., Yang H., et al. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J Proteome Res 2009, 8:4889-4905.
10. Srinivasan S., Thangavelu M., Zhang L., Green K.B., Nichols K.K. iTRAQ quantitative proteomics in the analysis of tears in dry eye patients. Invest Ophthalmol Vis Sci 2012, 53:5052-5059.
11. Boehm N., Funke S., Wiegand M., Wehrwein N., Pfeiffer N., Grus F.H. Alterations in the tear proteome of dry eye patients-a matter of the clinical phenotype. Invest Ophthalmol Vis Sci 2013, 54:2385-2392.
12. Soria J., Duran J.A., Etxebarria J., Merayo J., González N., Reigada R., et al. Tear proteome and protein network analyses reveal a novel pentamarker panel for tear film characterization in dry eye and meibomian gland dysfunction. J Proteomics 2013, 78:94-112.
13. Tong L., Zhou L., Beuerman R.W., Zhao S.Z., Li X.R. Association of tear proteins with Meibomian gland disease and dry eye symptoms. Br J Ophthalmol 2011, 95:848-852.
14. Lema I., Brea D., Rodriguez-Gonzalez R., Diez-Feijoo E., Sobrino T. Proteomic analysis of the tear film in patients with keratoconus. Mol Vis 2010, 16:2055-2061.
15. Pannebaker C., Chandler H.L., Nichols J.J. Tear proteomics in keratoconus. Mol Vis 2010, 16:1949-1957.
16. Koo B.S., Lee D.Y., Ha H.S., Kim J.C., Kim C.W. Comparative analysis of the tear protein expression in blepharitis patients using two-dimensional electrophoresis. J Proteome Res 2005, 4:719-724.
17. Okrojek R., Grus F.H., Matheis N., Kahaly G.J. Proteomics in autoimmune thyroid eye disease. Horm Metab Res 2009, 41:465-470.
18. Matheis N., Okrojek R., Grus F.H., Kahaly G.J. Proteomics of tear fluid in thyroid-associated orbitopathy. Thyroid 2012, 22:1039-1045.
19. Csosz E., Boross P., Csutak A., Berta A., Tóth F., Póliska S., et al. Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy. J Proteomics 2012, 75:2196-2204.
20. Acera A., Suarez T., Rodriguez-Agirretxe I., Vecino E., Duran J.A. Changes in tear protein profile in patients with conjunctivochalasis. Cornea 2011, 30:42-49.
21. Ananthi S., Chitra T., Bini R., Prajna N.V., Lalitha P., Dharmalingam K. Comparative analysis of the tear protein profile in mycotic keratitis patients. Mol Vis 2008, 14:500-507.
22. Ananthi S., Venkatesh Prajna N., Lalitha P., Valarnila M., Dharmalingam K. Pathogen induced changes in the protein profile of human tears from Fusarium keratitis patients. PLoS One 2013, 8:e53018.
23. Wong T.T., Zhou L., Li J., Tong L., Zhao S.Z., Li X.R., et al. Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication. Invest Ophthalmol Vis Sci 2011, 52:7385-7391.
24. Peterson A.C., Russell J.D., Bailey D.J., Westphall M.S., Coon J.J. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol Cell Proteomics 2012, 11:1475-1488.
25. Gallien S., Duriez E., Crone C., Kellmann M., Moehring T., Domon B. Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer. Mol Cell Proteomics 2012, 11:1709-1723.
26. Bianco L., Bessant C. Free computational resources for designing selected reaction monitoring transitions. Proteomics 2010, 10:1106-1126.
27. Tambor V., Fucíková A., Lenco J., Kacerovský M., Rehácek V., Stulík J., et al. Application of proteomics in biomarker discovery: a primer for the clinician. Physiol Res 2010, 59:471-497.
28. Han B., Higgs R.E. Proteomics: from hypothesis to quantitative assay on a single platform. Guidelines for developing MRM assays using ion trap mass spectrometers. Brief Funct Genomic Proteomic 2008, 7:340-354.
29. Ong S.E., Foster L.J., Mann M. Mass spectrometric-based approaches in quantitative proteomics. Methods 2003, 29:124-130.
30. Kuzyk M.A., Smith D., Yang J., Cross T.J., Jackson A.M., Hardie D.B., et al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics 2009, 8:1860-1877.
31. Barnidge D.R., Goodmanson M.K., Klee G.G., Muddiman D.C. Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-MS/MS using protein cleavage and isotope dilution mass spectrometry. J Proteome Res 2004, 3:644-652.
32. Masoudi S., Zhong L., Raftery M.J., Stapleton F.J., Willcox M.D. Method development for quantification of five tear proteins using selected reaction monitoring (SRM) mass spectrometry. Invest Ophthalmol Vis Sci 2014, 55(2):767-775.
33. Brun V., Masselon C., Garin J., Dupuis A. Isotope dilution strategies for absolute quantitative proteomics. J Proteomics 2009, 72(5):740-749.
34. Wiśniewski J.R., Zougman A., Nagaraj N., Mann M. Universal sample preparation method for proteome analysis. Nat Methods 2009, 6(5):359-362.
35. Lange V., Malmström J.A., Didion J., King N.L., Johansson B.P., Schäfer J., et al. Targeted quantitative analysis of Streptococcus pyogenes virulence factors by multiple reaction monitoring. Mol Cell Proteomics 2008, 7:1489-1500.
36. Ohashi Y., Ishida R., Kojima T., Goto E., Matsumoto Y., Watanabe K., et al. Abnormal protein profiles in tears with dry eye syndrome. Am J Ophthalmol 2003, 136(2):291-299.
37. Dartt D.A. Tear lipocalin: structure and function. Ocul Surf 2011, 9(3):126-138.
38. Versura P., Nanni P., Bavelloni A., Blalock W.L., Piazzi M., Roda A., et al. Tear proteomics in evaporative dry eye disease. Eye (Lond) 2010, 24(8):1396-1402.
39. McKown R.L., Wang N., Raab R.W., Karnati R., Zhang Y., Williams P.B., et al. Lacritin and other new proteins of the lacrimal functional unit. Exp Eye Res 2009, 88(5):848-858.
40. Karnati R., Laurie D.E., Laurie G.W. Lacritin and the tear proteome as natural replacement therapy for dry eye. Exp Eye Res 2013, 117:39-52.
41. Berry M., Pult H., Purslow C., Murphy P.J. Mucins and ocular signs in symptomatic and asymptomatic contact lens wear. Optom Vis Sci 2008, 85(10):E930-E938.
42. Zhao H., Jumblatt J.E., TO Wood, Jumblatt M.M. Quantification of MUC5AC protein in human tears. Cornea 2001, 20(8):873-877.
43. Zhou L., Beuerman R.W., Ang L.P., Chan C.M., Li S.F., Chew F.T., et al. Elevation of human alpha-defensins and S100 calcium-binding proteins A8 and A9 in tear fluid of patients with pterygium. Invest Ophthalmol Vis Sci 2009, 50:2077-2086.
44. Li J., Riau A.K., Setiawan M., Mehta J.S., Ti S.E., Tong L., et al. S100A expression in normal corneal-limbal epithelial cells and ocular surface squamous cell carcinoma tissue. Mol Vis 2011, 17:2263-2271.
45. Chen Y., Koppaka V., Thompson D.C., Vasiliou V. Focus on molecules: ALDH1A1: from lens and corneal crystallin to stem cell marker. Exp Eye Res 2012, 102:105-106.
46. Velez V.F., Romano J.A., McKown R.L., Green K., Zhang L., Raab R.W., et al. Tissue transglutaminase is a negative regulator of monomeric lacritin bioactivity. Invest Ophthalmol Vis Sci 2013, 54(3):2123-2132.
47. Loimaranta V., Hytonen J., Pulliainen A.T., Sharma A., Tenovuo J., Stromberg N., et al. Leucine-rich repeats of bacterial surface proteins serve as common pattern recognition motifs of human scavenger receptor gp340. J Biol Chem 2009, 284(28):18614-18623.
48. Schulz B.L., Oxley D., Packer N.H., Karlsson N.G. Identification of two highly sialylated human tear-fluid DMBT1 isoforms: the major high-molecular-mass glycoproteins in human tears. Biochem J 2002, 366(Pt 2):511-520.
49. Cejkova J., Ardan T., Jirsova K., Jechova G., Malec J., Simonova Z., et al. The role of conjunctival epithelial cell xanthine oxidoreductase/xanthine oxidase in oxidative reactions on the ocular surface of dry eye patients with Sjogren's syndrome. Histol Histopathol 2007, 22(9):997-1003.
50. Osakabe Y., Amano S., Fukuoka S., Yamagami S. Histologic evaluation of a cornea in a patient with apolipoprotein A-I deficiency. Cornea 2008, 27(3):372-373.
51. Nyunt A.K., Ishida Y., Yu Y., Shimada S. Topical apolipoprotein A-1 may have a beneficial effect on the corneal epithelium in a mouse model of dry eye: a pilot study. Eye Contact Lens 2008, 34(5):287-292.
52. Reitz C., Breipohl W., Augustin A., Bours J. Analysis of tear proteins by one- and two-dimensional thin-layer iosoelectric focusing, sodium dodecyl sulfate electrophoresis and lectin blotting. Detection of a new component: cystatin C. Graefes Arch Clin Exp Ophthalmol 1998, 236(12):894-899.
53. Kitteringham N.R., Jenkins R.E., Lane C.S., Elliott V.L., Park B.K. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:1229-1239.
54. Kanamori T., Takakura K., Mandai M., Kariya M., Fukuhara K., Sakaguchi M., et al. Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours. Mol Hum Reprod 2004, 10(10):735-742.
55. Jumblatt M.M., Imbert Y., Young W.W., Foulks G.N., Steele P.S., Demuth D.R. Glycoprotein 340 in normal human ocular surface tissues and tear film. Infect Immun 2006, 74:4058-4063.